Top five models for immuno-oncology studies

Scientists at Labcorp have run close to 3,500 preclinical immuno-oncology studies over the past five years. While new models continue to be developed, our scientists have found the following to be their commonly used "workhorse" models, time-tested and optimized for evaluating a wide range of therapeutic approaches. These diverse models offer several histotypes for test agent development, with Labcorp offering the range of capabilities needed to support them.

Copy and paste this URL:

https://biopharma.labcorp.com/latest-thinking/explore-library/detail.html/covance/assetLibrary/salessheets/Top-Five-Models-for-Immuno-Oncology-Studies-SSSAMLO008.pdf